Skip to main content
    R

    Roche Holding Ltd (RHHBY)

    Drug Manufacturers - General

    $60.30
    -0.20 (-0.33%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Roche Holding Ltd (RHHBY) Financials: Revenue, Profit and Cash Flow

    Updated Jan 29, 2026. Financial statements from company filings, amounts in CHF.

    Roche Holding reported revenue of CHF 63.36B for the fiscal year ended Dec 31, 2025, up 1.5% from the year before. That year, net income was CHF 12.88B with a net margin of 20.3%, operating cash flow was CHF 17.03B and free cash flow was CHF 13.45B. The quarter ended Dec 31, 2025 had revenue of CHF 30.32B and net income of CHF 5.42B.

    Revenue and Margins

    The operating margin was 29.2% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from CHF 59.50B, a compound annual rate of 0.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 202563.36B+1.5%73.7%29.2%20.3%
    Dec 202462.40B+3.2%73.9%21.5%13.3%
    Dec 202360.44B-8.2%74.2%25.5%19.0%
    Dec 202265.81B+4.8%72.7%26.6%18.9%
    Dec 202162.80B+7.7%68.6%27.5%22.2%
    Dec 202058.32B-8.5%72.0%31.8%24.5%
    Dec 201963.75B+7.1%72.7%33.0%21.2%
    Dec 201859.50BN/A72.2%31.8%17.6%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 55.6% from the year before. In the quarter ended Dec 2025, net income rose 168.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue63.36B62.40B60.44B65.81B62.80B58.32B63.75B59.50B
    Cost of revenue16.64B16.28B15.60B17.94B19.70B16.35B17.39B16.52B
    Gross profit46.71B46.11B44.84B47.88B43.10B41.97B46.37B42.98B
    Research and development12.75B15.30B14.20B15.22B14.80B13.01B12.77B12.09B
    Operating income18.48B13.42B15.39B17.48B17.28B18.54B21.03B18.92B
    Net income12.88B8.28B11.50B12.42B13.93B14.29B13.50B10.50B
    EBITDA21.70B16.62B18.41B24.07B22.19B22.97B25.34BN/A
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemDec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020
    Revenue30.32B15.92B31.64B30.76B30.66B29.78B30.99B32.30B32.09B30.71B29.04B29.28B
    Gross profit21.75B12.05B22.83B23.28B20.66B22.24B21.90B22.55B21.62B21.47B20.59B21.37B
    Operating income7.05B5.17B4.35B9.07B5.94B9.46B7.90B10.27B8.05B9.23B7.88B9.84B
    Net income5.42B3.71B2.02B6.26B4.36B7.14B3.89B8.53B6.13B7.80B6.22B8.08B
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of CHF 31.67B exceeded cash and equivalents by 26.08B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets100.82B101.80B90.47B88.15B92.32B86.14B83.09B78.52B
    Current assets38.77B40.04B33.45B33.82B35.63B32.94B31.25B32.24B
    Cash and equivalents5.59B6.97B5.38B4.99B6.85B5.73B6.08B6.68B
    Total liabilities62.89B65.64B57.20B56.14B63.97B46.37B47.22B48.15B
    Short-term debt4.21B3.93B4.40B3.96B15.12B4.00B1.70B2.69B
    Long-term debt27.46B30.72B24.81B21.39B16.08B10.22B12.67B16.08B
    Shareholder equity33.84B31.77B29.32B27.99B24.49B36.34B32.75B27.62B
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemDec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020
    Total assets100.82B94.77B101.80B95.79B90.47B84.37B88.15B86.74B92.32B87.89B86.14B80.36B
    Total liabilities62.89B61.72B65.64B62.91B57.20B54.03B56.14B57.79B63.97B46.45B46.37B45.55B
    Cash and equivalents5.59B7.55B6.97B4.82B5.38B3.72B4.99B4.32B6.85B5.00B5.73B3.77B
    Shareholder equity33.84B28.68B31.77B28.94B29.32B26.52B27.99B25.19B24.49B37.81B36.34B31.51B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 79.0% of operating cash flow. Dividends and share repurchases together came to 66.5% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow17.03B20.09B16.09B17.89B20.57B18.16B22.39B19.98B
    Capital expenditures3.58B5.01B4.65B4.55B4.55B6.69B3.50B4.04B
    Free cash flow13.45B15.09B11.45B13.34B16.02B11.47B18.88B15.94B
    Dividends paid8.01B7.65B7.59B7.45B7.77B7.70B7.45B7.25B
    Share repurchases942.63M1.13B1.14B1.26B18.99B2.13B947.00M448.00M
    Investing cash flow-8.32B-11.39B-10.64B-3.57B-6.55B-9.08B-8.63B-7.20B
    Financing cash flow-9.72B-6.82B-4.24B-15.72B-12.70B-9.24B-14.17B-10.69B
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemDec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
    Operating cash flow11.61B6.12B11.68B7.91B7.91B7.59B8.61B
    Capital expenditures2.17B1.56B1.80B1.72B2.67B1.97B2.53B
    Free cash flow9.44B4.56B9.88B6.19B5.23B5.61B6.08B
    Last 7 quarters

    Frequently Asked Questions About RHHBY

    What is Roche Holding's annual revenue?

    Roche Holding reported revenue of CHF 63.36B for the fiscal year ended Dec 31, 2025.

    How fast is Roche Holding's revenue growing?

    Revenue was up 1.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.3%.

    Is Roche Holding profitable?

    Yes. Roche Holding reported net income of CHF 12.88B for the fiscal year ended Dec 31, 2025, with a net margin of 20.3%.

    How much free cash flow does RHHBY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of CHF 17.03B minus capital expenditures of CHF 3.58B produced free cash flow of CHF 13.45B.

    How much debt does Roche Holding have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of CHF 27.46B, short-term debt of CHF 4.21B and cash and equivalents of CHF 5.59B.